InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（11 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
11
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Burke Steven Keith, Vice-Président Senior et Médecin-Chef. Director active across 1 company, notably Akebia Therapeutics, Inc.. Cumulatively, 16 filings have been published. Breakdown: 0 buy · 11 sells. Total volume traded: €180k. Activity tracked since 31 August 2021. The latest transaction was disclosed on 2 February 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Burke Steven Keith
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报16 总计
21,582 股@ US$1.3914.1% 占其流量Common StockSEC:0001619834-26-000002:0
204,000 股0Common StockSEC:0001619834-26-000001:0
7,144 股@ US$1.838.0% 占其流量Common StockSEC:0001562180-25-001997:0
194,900 股0Common StockSEC:0001562180-25-000916:0
27,000 股@ US$1.1518.3% 占其流量Common StockSEC:0001562180-24-003948:0
7,169 股@ US$1.586.7% 占其流量Common StockSEC:0001562180-24-002020:0
8,367 股@ US$1.527.5% 占其流量Common StockSEC:0001562180-24-001993:0
202,200 股0Common StockSEC:0001562180-24-000970:0
63,567 股@ US$1.06839.8% 占其流量Common StockSEC:0001562180-23-004254:0
6,613 股@ US$0.87753.5% 占其流量Common StockSEC:0001562180-23-002199:0
7,539 股@ US$0.81323.7% 占其流量Common StockSEC:0001562180-23-002040:0
196,200 股0Common StockSEC:0001562180-23-000830:0
1,147 股@ US$0.36250.3% 占其流量Common StockSEC:0001562180-22-006402:0
200,000 股0Common StockSEC:0001562180-22-004031:0
7,400 股@ US$2.15487.9% 占其流量Common StockSEC:0001562180-22-002165:0
1,042 股@ US$2.831.4% 占其流量Common StockSEC:0001562180-21-005744:0
16 条申报中的 16 条
About Burke Steven Keith
Burke Steven Keith is Senior Vice President and Chief Medical Officer. He has filed 16 filings in total, and in the 16 recent filings available, all transactions are sales in Akebia Therapeutics, Inc., for a combined amount of EUR 179742, with a period from 2021-09-02 to 2026-02-04.
